Literature DB >> 1987876

Zidovudine-induced macular edema.

R G Lalonde1, J G Deschênes, C Seamone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1987876     DOI： 10.7326/0003-4819-114-4-297

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  6 in total

Review 1.  Antiretroviral therapy: reverse transcriptase inhibition.

Authors:  K J Connolly; S M Hammer
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

Review 2.  Zidovudine. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  Michelle I Wilde; Heather D Langtry
Journal:  Drugs       Date:  1993-09       Impact factor: 9.546

3.  Cystoid macular oedema and cytomegalovirus retinitis in patients with HIV disease treated with highly active antiretroviral therapy.

Authors:  N Cassoux; L Lumbroso; B Bodaghi; L Zazoun; C Katlama; P LeHoang
Journal:  Br J Ophthalmol       Date:  1999-01       Impact factor: 4.638

Review 4.  Drug-induced macular edema.

Authors:  Olga E Makri; Ilias Georgalas; Constantine D Georgakopoulos
Journal:  Drugs       Date:  2013-06       Impact factor: 9.546

5.  A Retrospective Review of Serious Adverse Drug Reaction Reports in the Nigerian VigiFlow Database from September 2004 to December 2016.

Authors:  Comfort Kunak Ogar; Abiodun Abiola; Daniel Yuah; Ali Ibrahim; Ibrahim Adekunle Oreagba; Emmanuel C Amadi; Mojisola Christianah Adeyeye; Kazeem Adeola Oshikoya
Journal:  Pharmaceut Med       Date:  2019-04

6.  A Rare Case of Didanosine-Induced Mid-Peripheral Chorioretinal Atrophy Identified Incidentally 11 Years after the Drug Cessation.

Authors:  Heba Joharjy; Pierre-Jean Pisella; Isabelle Audo; Marie Laure Le-Lez
Journal:  Medicina (Kaunas)       Date:  2022-05-30       Impact factor: 2.948
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.